http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-050167-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6831b19bfc354357342f7c7da79fc162
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
filingDate 2005-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_468e6ab787eee4807974068cbab3a165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed8e7f01c6a772ec3ad1a82e5f44a0f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbb605c9f4a0c57f5f825dddf955b686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e7a9c29312b658d4e1140f00172c821
publicationDate 2006-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-050167-A1
titleOfInvention PIPERIDINE COMPOUND AND PROCEDURE TO PREPARE THE SAME
abstract This refers to a piperidine compound represented by formula (1) wherein: ring A is an optionally substituted benzene ring, ring B is an optionally substituted benzene ring, R1 is H atom or a substituent for the amino group , R2 is an H atom, an optionally substituted hydroxyl group, an optionally substituted amino group, an optionally substituted alkyl group, a substituted carbonyl group or a halogen atom, Z is an O or -N atom (R3) -, R3 is an atom of H or an optionally substituted alkyl group; R4a and R4b can be the same or different, and each is an H atom or an optionally substituted alkyl group, or they can be linked together at both ends to form an alkylene group, or a pharmaceutically acceptable salt thereof that has an excellent antagonistic action. to the tachykinin receptor.
priorityDate 2004-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310

Total number of triples: 36.